Form 4: Angiodynamics CEO Reports Stock Transaction
Insider Transaction (Form 4)
James C Clemmer, President and CEO and a Director of Angiodynamics Inc, reported multiple transactions in common stock on July 22, 2026.
Summary
- Option exercise/conversion: acquired 52,358 Common Stock on July 22, 2026; holds 889,176 after (Direct).
- Tax/exercise-price withholding: disposed of 26,728 Common Stock at $13.82 ($369,381) on July 22, 2026; holds 862,448 after (Direct).
- Option exercise/conversion: disposed of 184,361 Performance Right on July 22, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
James C Clemmer — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-22 | Option exercise/conversion | Common Stock | 52,358 | — | — | 889,176 |
| 2026-07-22 | Tax/exercise-price withholding | Common Stock | 26,728 | $14 | $369.4K | 862,448 |
| 2026-07-22 | Option exercise/conversion | Performance Right | 184,361 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-22 | Option exercise/conversion (52,358 shares) |
| 2026-07-22 | Tax/exercise-price withholding (26,728 shares) |
| 2026-07-22 | Option exercise/conversion (184,361 shares) |
Keywords
insider transaction, Form 4, ANGO, ANGIODYNAMICS INC, neutral, James C Clemmer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.